Yeah never in my wildest dreams would i ever have expected 3 out...

Yeah never in my wildest dreams would i ever have expected 3 out 3 trials all looking very positive so far, it's early days i know , but slowly but surely this incredible team are delivering in spades.
Talking about the US ruster, the three companies we used to compare ourselves with as our peer comparisons, Minded, Compass, and Atai, all were over One Billion US Market Cap companies, i think Compass touched 2B, and Atai 3B last year.
Well now we have overtaken Mindmed, and Compass and almost equal with Atai that is if you take away there much stronger cash positions into account. So on an EV basis we are ahead of two and pretty well level with Atai who were 3B MC last year.
Does that mean that if Biotech stocks in the US hadn't been so smashed , we could in theory have already been a one to two Billion MC company.

So in actual fact we are looking pretty good here, and as you say we could ride a pretty significant upswing for Biotech companies in the US hopefully soon.